Redx Pharma Plc (LON:REDX)

Redx Pharma Plc (LON:REDX)


Share Price
10.15 p
Change
1.65 (19.41 %)
Market Cap
£12.84 m
Proactive Investors - Run By Investors For Investors

Redx Pharma Plc

Focused on the development of novel medicines to validated anti-cancer and fibrosis targets in areas of unmet need

Redx Pharma uses its proven drug discovery expertise to generate development candidates that it will take into the clinic and then partner. The company’s product development strategy has three interrelated components:

Cancer: RXC004, our lead clinical asset
Build on...

EPIC: REDX
Market: AIM:REDX
52-week High/Low: 14.84p / 4.75p
Sector: Pharma & Biotech
Market Cap: £12.84 m
Website: www.redxpharma.com
col 3
col 4
col 5
col 6

Redx Pharma Plc RNS Announcements

Date Epic Announcement
10/07/2019 REDX Sale of pan-RAF inhibitor programme
10/06/2019 REDX Interim Results for six months ended 31 March 2019
10/06/2019 REDX Short-term Debt Funding Secured
03/05/2019 REDX Update on Plans to Strengthen Balance Sheet
29/03/2019 REDX Redx to present two posters at AACR 2019
28/02/2019 REDX Issue of Warrants and Change to Lease Agreement
14/02/2019 REDX Directorate Update
12/02/2019 REDX New in vivo data on ROCK2
06/02/2019 REDX Receipt of Outstanding Loan
31/01/2019 REDX Deinove return rights to Redx Programme
23/01/2019 REDX Results of Annual General Meeting
21/01/2019 REDX RXC004 Trial Approval
10/01/2019 REDX Second Price Monitoring Extn
10/01/2019 REDX Price Monitoring Extension
03/01/2019 REDX Redx to present at 2019 Biotech Showcase event
28/12/2018 REDX Publication of Annual Report and Accounts
30/11/2018 REDX First RXC006 data for treatment of fibrosis
19/11/2018 REDX CFO Announcement
19/11/2018 REDX Preliminary Results for year ended 30 Sept 2018
14/11/2018 REDX Redx announces new drug development candidate
05/11/2018 REDX Preclinical data presented at cancer conference
31/10/2018 REDX Notice of Results
29/10/2018 REDX Redx notes election of Lisa Anson to UK BIA BOD
26/10/2018 REDX Details from Redx ROCK2 inhibitor poster
22/10/2018 REDX Redx ROCK2 inhibitors poster to be presented
04/09/2018 REDX Redx Pharma Announces Way Forward For RXC004
04/06/2018 REDX Directorate Update and Grant of Options
30/05/2018 REDX Interim Results
25/04/2018 REDX Share Purchase by Chairman
25/04/2018 REDX Second Price Monitoring Extn

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use